Fate of a bioactive fluorescent wortmannin derivative in cells

被引:16
作者
Barnes, Katie R. [1 ,2 ]
Blois, Joseph [1 ,2 ]
Smith, Adam [1 ,2 ]
Yuan, Hushan [1 ,2 ]
Reynolds, Fred [1 ,2 ]
Weissleder, Ralph [1 ,2 ]
Cantley, Lewis C. [3 ]
Josephson, Lee [1 ,2 ]
机构
[1] Massachusetts Gen Hosp, Ctr Mol Imaging Res, Charlestown, MA 02129 USA
[2] Harvard Univ, Sch Med, Dept Syst Biol, Charlestown, MA 02129 USA
[3] Beth Israel Deaconess Med Ctr, Div Signal Transduct, Boston, MA 02115 USA
关键词
D O I
10.1021/bc7002204
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Here, we report on NBD-Wm, a fluorescent wortmannin (Wm) probe that maintains the bioactivity of Wm as an inhibitor of PI3 kinase and as an antiproliferative agent. The attachment of the NBD fluorochrome permits NBD-Wm in cells to be monitored by NBD fluorescence-based methods such as FACS or fluorescence microscopy or with an anti-NBD antibody. The fluorescence of NBD-Wm treated cells reached a peak at 1.5 h and then decreased because of the extrusion of a fluorescent compound into the culture media. Cells accumulated N-BD-Wm to levels about 30-fold higher than those in the media. NBD-Wm modified five major proteins, with the modification of the catalytic subunit of PI3 kinase being a minor band. The bioactivity of NBD-Wm, coupled with a variety of techniques available for determining its disposition, suggest that NBD-Wm can be a useful tool in understanding the mechanism of action of viridins.
引用
收藏
页码:130 / 137
页数:8
相关论文
共 37 条
[31]  
YANO H, 1993, J BIOL CHEM, V268, P25846
[32]   A cell-permeable, activity-based probe for protein and lipid kinases [J].
Yee, M ;
Fas, SC ;
Stohlmeyer, MM ;
Wandless, TJ ;
Cimprich, KA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (32) :29053-29059
[33]   PWT-458, a novel pegylated-17-hydroxywortmannin, inhibits phosphatidylinositol 3-kinase signaling and suppresses growth of solid tumors [J].
Yu, K ;
Lucas, J ;
Zhu, TM ;
Zask, A ;
Gaydos, C ;
Toral-Barza, L ;
Gu, JX ;
Li, FB ;
Chaudhary, I ;
Cai, P ;
Lotvin, J ;
Petersen, R ;
Ruppen, M ;
Fawzi, M ;
Ayral-Kaloustian, S ;
Skotnicki, J ;
Mansour, T ;
Frost, P ;
Gibbons, J .
CANCER BIOLOGY & THERAPY, 2005, 4 (05) :538-545
[34]   Wortmannin-C20 conjugates generate wortmannin [J].
Yuan, HS ;
Luo, J ;
Weissleder, R ;
Cantley, L ;
Josephson, L .
JOURNAL OF MEDICINAL CHEMISTRY, 2006, 49 (02) :740-747
[35]   Synthesis and activity of C11-modified wortmannin probes for P13 kinase [J].
Yuan, HS ;
Luo, J ;
Field, S ;
Weissleder, R ;
Cantley, L ;
Josephson, L .
BIOCONJUGATE CHEMISTRY, 2005, 16 (03) :669-675
[36]   Covalent reactions of Wortmannin under physiological conditions [J].
Yuan, Hushan ;
Barnes, Katie R. ;
Weissleder, Ralph ;
Cantley, Lewis ;
Josephson, Lee .
CHEMISTRY & BIOLOGY, 2007, 14 (03) :321-328
[37]   Pegylated wortmannin and 17-hydroxywortmannin conjugates as phosphoinositide 3-kinase inhibitors active in human tumor xenograft models [J].
Zhu, TM ;
Gu, JX ;
Yu, K ;
Lucas, J ;
Cai, P ;
Tsao, R ;
Gong, YM ;
Li, FB ;
Chaudhary, I ;
Desai, P ;
Ruppen, M ;
Fawzi, M ;
Gibbons, J ;
Ayral-Kaloustian, S ;
Skotnicki, J ;
Mansour, T ;
Zask, A .
JOURNAL OF MEDICINAL CHEMISTRY, 2006, 49 (04) :1373-1378